Baker Ellis Asset Management LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,269 shares of the healthcare conglomerate’s stock after selling 30 shares during the quarter. Baker Ellis Asset Management LLC’s holdings in UnitedHealth Group were worth $472,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors have also recently added to or reduced their stakes in the company. Accel Wealth Management acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Atlas Private Wealth Advisors increased its stake in shares of UnitedHealth Group by 46.2% in the first quarter. Atlas Private Wealth Advisors now owns 95 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 30 shares during the period. Sage Private Wealth Group LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $36,000. IronBridge Private Wealth LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $37,000. Finally, Costello Asset Management INC increased its position in UnitedHealth Group by 500.0% during the 4th quarter. Costello Asset Management INC now owns 120 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 100 shares during the period. 86.03% of the stock is owned by institutional investors.
A number of analysts have weighed in on the stock. Barclays increased their target price on shares of UnitedHealth Group from $405.00 to $435.00 and gave the company an “overweight” rating in a research report on Thursday, April 22nd. Truist increased their price target on UnitedHealth Group from $420.00 to $450.00 in a report on Wednesday, April 14th. Credit Suisse Group increased their price target on UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, April 22nd. Morgan Stanley raised their target price on UnitedHealth Group from $462.00 to $515.00 and gave the company an “overweight” rating in a research report on Thursday, April 22nd. Finally, Oppenheimer raised their target price on UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, April 22nd. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $409.61.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm had revenue of $70.20 billion for the quarter, compared to analysts’ expectations of $69.13 billion. During the same period in the previous year, the firm earned $3.72 earnings per share. The business’s revenue was up 9.0% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Incorporated will post 16.75 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, March 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.23%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.
In related news, CAO Thomas E. Roos sold 619 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the sale, the chief accounting officer now directly owns 31,908 shares in the company, valued at $10,335,001.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Monday, April 19th. The shares were sold at an average price of $391.25, for a total value of $978,125.00. Following the sale, the director now owns 154,181 shares in the company, valued at $60,323,316.25. The disclosure for this sale can be found here. Insiders have sold 20,420 shares of company stock worth $7,532,962 over the last 90 days. 0.80% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.
See Also: Bar Chart
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.